Phase II study of palonosetron, aprepitant and dexamethasone to prevent nausea and vomiting induced by multiple-day emetogenic chemotherapy

ConclusionsThe examined combination antiemetic therapy was effective and well-tolerated in patients with TGCTs receiving 5-day cisplatin-based combination chemotherapy.

http://link.springer.com/10.1007/s00520-017-3967-2

Source: Supportive Care in Cancer - March 29, 2018 Category: Cancer & Oncology Source Type: research